JT
ICPT

Jump Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jump Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,400
Closed -$342K – 606
2016
Q2 		$342K Buy
+2,400
New +$350K 0.02% 506
2015
Q3 		– Sell
-100
Closed -$24K – 1074
2015
Q2 		$24K Buy
+100
New +$26.6K ﹤0.01% 1028
2014
Q4 		– Sell
-1,200
Closed -$284K – 1237
2014
Q3 		$284K Buy
1,200
+200
+20% +$51K 0.01% 544
2014
Q2 		$237K Buy
+1,000
New +$264K 0.01% 487

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jump Trading's ICPT Position: Q4 2019 in Review

Jump Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 3,121 shares — an estimated $207K sold.

Jump Trading first reported a position in ICPT in Q2 2014 and held it in 5 quarters. The position peaked at $294K in Q3 2014. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

  • Jump Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Jump Trading sold 3,121 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $207K.
  • Jump Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
  • Jump Trading's Intercept Pharmaceuticals, Inc. position peaked at $294K in Q3 2014.
  • 215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Jump Trading's 13F filing for Q4 2019, filed 14 Feb 2020.